The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: cymbalta     Quarter: 2016Q3

Total Records: 658     Number of Pages: 33

DRUGNAME PT EventCount
CYMBALTA Drug ineffective for unapproved indication 8
CYMBALTA Heart rate increased 8
CYMBALTA Hypersomnia 8
CYMBALTA Hypoaesthesia 8
CYMBALTA Migraine 8
CYMBALTA Mood altered 8
CYMBALTA Nerve injury 8
CYMBALTA Neuralgia 8
CYMBALTA Vision blurred 8
CYMBALTA Activities of daily living impaired 7
CYMBALTA Autoimmune disorder 7
CYMBALTA Cold sweat 7
CYMBALTA Cough 7
CYMBALTA Drug dependence 7
CYMBALTA Erythema 7
CYMBALTA Hallucination 7
CYMBALTA Hepatic function abnormal 7
CYMBALTA Incorrect dose administered 7
CYMBALTA Infection 7
CYMBALTA Neuropathy peripheral 7

Total Records: 658     Number of Pages: 33